Related Experiment Videos
Gene expression patterns in AIDS versus non-AIDS-related diffuse large B-cell lymphoma
Lisa Patrone1, Sarah E Henson, Jelena Teodorovic
1Department of Microbiology, Immunology, & Molecular Genetics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA 90095-1732, USA.
Experimental and Molecular Pathology
|April 25, 2003
Summary
Diffuse large B-cell lymphoma (DLBCL) is more common and severe in AIDS patients. This study found no specific gene expression differences, suggesting immune system decline drives AIDS-DLBCL severity.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Diffuse large B-cell lymphoma (DLBCL) presents with higher incidence and mortality in individuals with Acquired Immunodeficiency Syndrome (AIDS).
- Previous research identified TCL1 proto-oncogene overexpression in AIDS-DLBCL, suggesting its role in disease pathogenesis.
- The cellular microenvironment and distinct tumorigenic mechanisms are potential factors contributing to these observed differences.
Purpose of the Study:
- To identify additional genes contributing to the differential pathogenesis of DLBCL in AIDS patients.
- To investigate whether altered gene expression profiles distinguish AIDS-DLBCL from non-AIDS DLBCL.
Main Methods:
- Gene subtraction methodology was employed to identify potential candidate genes in AIDS-DLBCL.
- Candidate genes were annotated and further screened using miniarray analysis across multiple patient samples.
- Expression patterns of 18 selected candidate genes were analyzed in both AIDS-DLBCL and DLBCL cohorts.
Main Results:
- Gene subtraction identified over 1800 potential candidates, reduced to 18 for further analysis after annotation and screening.
- The 18 candidate genes exhibited distinct expression patterns in both AIDS-DLBCL and DLBCL.
- Unlike TCL1, none of the 18 candidate genes were preferentially associated with AIDS-DLBCL compared to DLBCL.
Conclusions:
- The study did not find specific gene expression profiles that differentiate AIDS-DLBCL from DLBCL, apart from previously identified TCL1.
- The findings suggest that compromised immune surveillance, rather than unique genetic alterations, likely underlies the increased incidence and severity of DLBCL in AIDS patients.